MAP 2020 Virtual Congress Brochure - European Society for

put the Unicancer’s R&D in the best position to address your research challenges ABOUT UNICANCER Unicancer represents a federation of French Comprehensive Cancer Centres (FCCCs), 18 private, non-profit hospitals located throughout France FCCCs are dedicated to fighting cancer through a threefold mission of patient care, research and education

We’re inventing the cancerology of tomorrow

clinics, etc ) in France and abroad R&D UNICANCER’s mission is to implement the global research strategy conducted by UNICANCER, and in particular: • focus on scientifi c questions in areas that are insuﬃ ciently covered by the pharmaceutical industry (rare cancers, surgery, radiotherapy, epidemiology, etc ) and to facilitate patient access

EORTC, Unicancer, INCA, Groupes coopératifs Francais

EORTC, Unicancer, INCA, Groupes coopératifs Francais JY Blay Pdt GSF-GETO/ Netsarc Dir EuroSARC ( FP7 278472) Dir LYRIC DG Centre Léon Bérard

CANCER GENOMIC PLATFORM

Comparative genomic hybridisation array and DNA sequencing to

for biopsy in 18 centres in France Comparative genomic hybridisation (CGH) array and Sanger sequencing on PIK3CA (exon 10 and 21) and AKT1 (exon 4) were used to assess metastatic biopsy samples in ﬁ ve centres

Unicancer et Bristol Myers Squibb signent un partenariat

Unicancer est aussi le premier promoteur académique d'essais cliniques en oncologie, à l'échelle européenne, avec 90 essais cliniques actifs promus, près de 6 500 patients inclus, + de 55 000 patients enregistrés dans la base de données ESME Reconnu comme leader de la recherche en France, le réseau Unicancer bénéficie

Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid